Lucira Health
Lucira Health (formerly Diassess Inc.) was a molecular diagnostics company based in Emeryville, California that developed single-use, disposable RT-LAMP test kits designed for at-home use. Its Lucira COVID-19 All-In-One Test Kit received the first FDA Emergency Use Authorization for an over-the-counter at-home molecular COVID-19 test, and the company later introduced the first at-home combination COVID-19 and influenza (flu) test. Lucira Health filed for Chapter 11 bankruptcy in February 2023 and its assets were subsequently acquired by Pfizer. The company is a consumer medical-device and diagnostics business; it published no public developer API, developer portal, or machine-readable API specification. This profile is maintained in the API Evangelist network as a company record; the legacy lucirahealth.com domain is now managed under Pfizer's email/DNS infrastructure and no longer serves a working web presence.
Lucira Health is profiled on the APIs.io network. Tagged areas include Company, Diagnostics, Health, Medical Devices, and COVID-19.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API